» Articles » PMID: 31587136

Anemia and Clinical Outcomes in Patients with Non-dialysis Dependent or Dialysis Dependent Severe Chronic Kidney Disease: a Danish Population-based Study

Overview
Journal J Nephrol
Publisher Springer
Specialty Nephrology
Date 2019 Oct 7
PMID 31587136
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Routine clinical evidence is limited on clinical outcomes associated with anemia in patients with severe chronic kidney disease (CKD).

Methods: We linked population-based medical databases to identify individuals with severe CKD (eGFR < 30 mL/min/1.73 m) in Northern Denmark from 2000 to 2016, including prevalent patients as of 1 January 2009 or incident patients hereafter into the study. We classified patients as non-anemic (≥ 12/≥ 13 g/dl hemoglobin (Hgb) in women/men), anemia grade 1 (10-12/13 g/dl Hgb in women/men), 2 (8-10 g/dl Hgb), and 3+ (< 8 g/dl Hgb), allowing persons to contribute with patient profiles and risk time in consecutively more severe anemia grade cohorts. Patients were stratified by dialysis status and followed for clinical outcomes.

Results: We identified 16,972 CKD patients contributing with a total of 28,510 anemia patient profiles, of which 3594 had dialysis dependent (DD) and 24,916 had non-dialysis dependent (NDD) severe CKD. Overall, 14% had no anemia, 35% grade 1 anemia, 44% grade 2 anemia and 17% grade 3+ anemia. Compared to patients with no anemia, adjusted hazard ratios (HRs) for NDD patients with grade 3+ anemia were elevated for incident dialysis (1.91, 95% CI 1.61-2.26), any acute hospitalization (1.74, 95% CI 1.57-1.93), all-cause death (1.82, 95% CI 1.70-1.94), and MACE (1.14, 95% CI 1.02-1.26). Similar HRs were observed among DD patients.

Conclusions: Among NDD or DD patients with severe CKD, presence and severity of anemia were associated with increased risks of incident dialysis for NDD patients and with acute hospitalizations, death and MACE for all patients.

Citing Articles

Finerenone Efficacy in Patients with Chronic Kidney Disease, Type 2 Diabetes, and Anemia in FIDELITY.

Singh A, James G, Anker S, Pitt B, Rossing P, Ruilope L JACC Adv. 2025; 4(2):101524.

PMID: 40021271 PMC: 11905162. DOI: 10.1016/j.jacadv.2024.101524.


Prognostic Features for Overall Survival in Male Diabetic Patients Undergoing Hemodialysis Using Elastic Net Penalized Cox Regression; A Machine Learning Approach.

Sharifi M, Mousavi-Roknabadi R, Ebrahimi V, Sadegh R, Dehbozorgi A, Hosseini-Marvast S Arch Iran Med. 2025; 28(1):9-17.

PMID: 40001324 PMC: 11862393. DOI: 10.34172/aim.27746.


Usage of the Anemia Control Model Is Associated with Reduced Hospitalization Risk in Hemodialysis.

Garbelli M, Baro Salvador M, Rincon Bello A, Samaniego Toro D, Bellocchio F, Fumagalli L Biomedicines. 2024; 12(10).

PMID: 39457532 PMC: 11504963. DOI: 10.3390/biomedicines12102219.


Association between red blood cells transfusion and 28-day mortality rate in septic patients with concomitant chronic kidney disease.

Chen L, Lu H, Lv C, Ni H, Yu R, Zhang B Sci Rep. 2024; 14(1):23769.

PMID: 39390059 PMC: 11466974. DOI: 10.1038/s41598-024-75643-3.


Roxadustat has risks of reversible central hypothyroidism in patients undergoing hemodialysis: a single-center retrospective cohort study.

Otsuka E, Kitamura M, Funakoshi S, Mukae H, Nishino T Ren Fail. 2024; 46(2):2410375.

PMID: 39378117 PMC: 11463015. DOI: 10.1080/0886022X.2024.2410375.


References
1.
. Chapter 1: Diagnosis and evaluation of anemia in CKD. Kidney Int Suppl (2011). 2014; 2(4):288-291. PMC: 4089684. DOI: 10.1038/kisup.2012.33. View

2.
Park H, Liu X, Henry L, Harman J, Ross E . Trends in anemia care in non-dialysis-dependent chronic kidney disease (CKD) patients in the United States (2006-2015). BMC Nephrol. 2018; 19(1):318. PMC: 6230235. DOI: 10.1186/s12882-018-1119-7. View

3.
Shih H, Wu C, Lin S . Physiology and pathophysiology of renal erythropoietin-producing cells. J Formos Med Assoc. 2018; 117(11):955-963. DOI: 10.1016/j.jfma.2018.03.017. View

4.
Babitt J, Lin H . Mechanisms of anemia in CKD. J Am Soc Nephrol. 2012; 23(10):1631-4. PMC: 3458456. DOI: 10.1681/ASN.2011111078. View

5.
Yotsueda R, Tanaka S, Taniguchi M, Fujisaki K, Torisu K, Masutani K . Hemoglobin concentration and the risk of hemorrhagic and ischemic stroke in patients undergoing hemodialysis: the Q-cohort study. Nephrol Dial Transplant. 2017; 33(5):856-864. DOI: 10.1093/ndt/gfx305. View